AlphaYouSJ
Schedule 13D filing
Sharpe Jeffrey Nathan disclosed a 5.2% stake in Conexeu Sciences Inc. (CNXU)
Sharpe Jeffrey Nathan reported owning 5.2% of Conexeu Sciences Inc. (CNXU) (1,500,000 shares) in a Schedule 13D filed Sep 15, 2026.
A 13D means the holder may push for changes at the company.
More CNXU insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.